Market Tracker

05/23 4:37pm ET

Trovagene Inc (NASDAQ:TROV)

0.2575
Delayed Data
As of 3:59pm ET
 -0.0025 / -0.96%
Today’s Change
0.24
Today|||52-Week Range
1.63
-16.26%
Year-to-Date
No recent news for Trovagene Inc.

Today’s Trading

Previous close0.26
Today’s open0.27
Day’s range0.26 - 0.28
Volume1,327,598
Average volume (3 months)1,664,870
Market cap$17.7M
Data as of 3:59pm ET, 05/23/2018

Growth & Valuation

Earnings growth (last year)+47.45%
Earnings growth (this year)+52.08%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+32.63%
P/E ratioNM
Price/Sales21.10
Price/Book2.42

Competitors

 Today’s
change
Today’s
% change
MBOTMicrobot Medical Inc+0.05+5.43%
ONCSOncoSec Medical Inc+0.01+0.64%
PTIProteostasis Therape...+0.06+1.21%
--BARD1 Life Sciences ...-0.00-11.11%
Data as of 4:00pm ET, 05/23/2018

Financials

Next reporting dateAugust 9, 2018
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$505.4K
Annual profit (last year)-$24.9M
Net profit margin-4,928.09%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Bill Welch
Chief Scientific Officer
Mark Erlander
Corporate headquarters
San Diego, California

Forecasts